MedPath

Impact of Patient Education on Benzodiazepine Use in the Elderly

Not Applicable
Withdrawn
Conditions
Anxiety
Insomnia
Interventions
Behavioral: Educational booklet
Registration Number
NCT02478593
Lead Sponsor
University of Vermont
Brief Summary

The overall goal of this research is to develop and test strategies to decrease potentially inappropriate medication use among the elderly.

Detailed Description

Specifically, the purpose of the study is to determine whether direct patient education is effective in decreasing benzodiazepine use in seniors.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Men and women
  • Full benefit members living in a SASH facility
  • 60 years old or older
  • Using at least 1 active short/medium/long acting benzodiazepine at time of recruitment
Read More
Exclusion Criteria
  • Inability to provide consent
  • Inability to communicate in English
  • Diagnosis of severe mental illness, dementia, seizure disorder
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Experimental groupEducational bookletGroup to receive educational booklet regarding risk/benefits of Benzodiazepine.
Primary Outcome Measures
NameTimeMethod
Benzodiazepine or non-benzodiazepine hypnotic medication useBaseline and 6 months post-intervention

Proportion of subjects using benzodiazepine or non-benzodiazepine hypnotic medication (such as zolpidem)

Secondary Outcome Measures
NameTimeMethod
Patient attempt to discontinuing benzodiazepine1 month and 6 months post-intervention

Novel patient reported measure regarding attempts to discontinue medication

Belief about Medicines Questionnaire (BMQ)Baseline and 6 months post-intervention

This is a validated instrument assessing patient beliefs regarding medication efficacy and safety

Patient knowledge regarding benzodiazepinesBaseline and 6 months post-intervention

Novel patient reported measure regarding knowledge of the potential risks and benefits of benzodiazepines

© Copyright 2025. All Rights Reserved by MedPath